Literature DB >> 9609349

Prolonged nonpulsatile left heart bypass with reduced systemic pulse pressure causes morphological changes in the aortic wall.

T Nishimura1, E Tatsumi, S Takaichi, Y Taenaka, Y Wakisaka, T Nakatani, T Masuzawa, Y Takewa, M Nakamura, S Endo, M Nakata, H Takano.   

Abstract

We investigated the morphological changes in the aorta due to reduced systemic pulse pressure in prolonged nonpulsatile left heart bypass (LHB). Nineteen adult goats were divided into 3 groups, the nonpulsatile group in which nonpulsatile LHB was conducted, the pulsatile group in which pulsatile LHB was conducted, and the control group used as the normal control. The average aortic pulse pressures were 12, 47, and 37 mm Hg, respectively. The descending aorta was subjected to morphological examination. In the nonpulsatile group, the wall was significantly thinner, and the volume ratio of smooth muscle cells (SMCs) was much lower. In terms of the SMC type classification, the proportion of SMCs with low activity and low contractility was higher, and the cell density of the SMCs was increased compared to those in the other groups. These results indicate that prolonged nonpulsatile LHB causes morphological atrophic changes in the aorta.

Entities:  

Mesh:

Year:  1998        PMID: 9609349     DOI: 10.1046/j.1525-1594.1998.06137.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  9 in total

1.  Simulation study of the Hemopump as a cardiac assist device.

Authors:  X Li; J Bai; P He
Journal:  Med Biol Eng Comput       Date:  2002-05       Impact factor: 2.602

2.  Optimum control of the Hemopump as a left-ventricular assist device.

Authors:  P He; J Bai; D D Xia
Journal:  Med Biol Eng Comput       Date:  2005-01       Impact factor: 2.602

Review 3.  Chronic nonpulsatile blood flow is compatible with normal end-organ function: implications for LVAD development.

Authors:  Satoshi Saito; Tomohiro Nishinaka
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

4.  Change in myocardial oxygen consumption employing continuous-flow LVAD with cardiac beat synchronizing system, in acute ischemic heart failure models.

Authors:  Akihide Umeki; Takashi Nishimura; Yoshiaki Takewa; Masahiko Ando; Mamoru Arakawa; Yuichiro Kishimoto; Tomonori Tsukiya; Toshihide Mizuno; Shunei Kyo; Minoru Ono; Yoshiyuki Taenaka; Eisuke Tatsumi
Journal:  J Artif Organs       Date:  2013-01-17       Impact factor: 1.731

5.  Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system.

Authors:  Chiyo Ootaki; Michifumi Yamashita; Yoshio Ootaki; Keiji Kamohara; Stephan Weber; Ryan S Klatte; William A Smith; Alex L Massiello; Steven N Emancipator; Leonard A R Golding; Kiyotaka Fukamachi
Journal:  J Thorac Cardiovasc Surg       Date:  2008-05-19       Impact factor: 5.209

6.  A Multi-Domain Simulation Study of a Pulsatile-Flow Pump Device for Heart Failure With Preserved Ejection Fraction.

Authors:  Caglar Ozturk; Luca Rosalia; Ellen T Roche
Journal:  Front Physiol       Date:  2022-01-25       Impact factor: 4.566

7.  Patient-Specific Computational Fluid Dynamics Reveal Localized Flow Patterns Predictive of Post-Left Ventricular Assist Device Aortic Incompetence.

Authors:  Rohan Shad; Alexander D Kaiser; Sandra Kong; Robyn Fong; Nicolas Quach; Cayley Bowles; Patpilai Kasinpila; Yasuhiro Shudo; Jeffrey Teuteberg; Y Joseph Woo; Alison L Marsden; William Hiesinger
Journal:  Circ Heart Fail       Date:  2021-06-18       Impact factor: 10.447

Review 8.  Complications of Continuous-Flow Mechanical Circulatory Support Devices.

Authors:  Harsh Patel; Raef Madanieh; Constantine E Kosmas; Satya K Vatti; Timothy J Vittorio
Journal:  Clin Med Insights Cardiol       Date:  2015-05-21

9.  Enhancement of Arterial Pressure Pulsatility by Controlling Continuous-Flow Left Ventricular Assist Device Flow Rate in Mock Circulatory System.

Authors:  Selim Bozkurt; Frans N van de Vosse; Marcel C M Rutten
Journal:  J Med Biol Eng       Date:  2016-06-25       Impact factor: 1.553

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.